At a glance
ClinicalIndex Comparison RecordN/ACompleted· 290 enrolled
Drug / intervention
TECCU Softwareother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Impact of Telemonitoring in the Management of Complex Inflammatory Bowel Disease in Spain: TECCU Multicenter Study
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa·interventional·Posted Sep 11, 2023·Updated Feb 6, 2026
In Brief
A clinical study evaluating TECCU Software for Inflammatory Bowel Disease and 3 related conditions. Completed, enrolled 290 participants across 30 sites.
Detailed Summary
M-TECCU is a study: multicenter, randomized and open. It consists of two parallel groups to compare the efficacy of the TECCU web-based telemonitoring system to achieve and maintain activity remission in patients with moderate-high complexity inflammatory bowel disease compared to usual clinical practice.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesSpain
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartSep 2020
Primary CompletionOct 2021
First PostedSep 2023
Study CompletionJun 2025
TodayJul 2026
First PostedSep 11, 2023
Enrollment StartSep 15, 2020
Primary CompletionOct 13, 2021
Study CompletionJun 5, 2025
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 2.8 years ago
Interventions
TECCU Softwareother
patient monitoring by software application